» Articles » PMID: 24077435

Detecting the Effect of Alzheimer's Disease on Everyday Motion Behavior

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2013 Oct 1
PMID 24077435
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Early detection of behavioral changes in Alzheimer's disease (AD) would help the design and implementation of specific interventions.

Objective: The target of our investigation was to establish a correlation between diagnosis and unconstrained motion behavior in subjects without major clinical behavior impairments.

Method: We studied everyday motion behavior in 23 dyads with one partner suffering from AD dementia and one cognitively healthy partner in the subjects' home, employing ankle-mounted three-axes accelerometric sensors. We determined frequency features obtained from the signal envelopes computed by an envelope detector for the carrier band 0.5 Hz to 5 Hz. Based on these features, we employed quadratic discriminant analysis for building models discriminating between AD patients and healthy controls.

Results: After leave-one-out cross-validation, the classification accuracy of motion features reached 91% and was superior to the classification accuracy based on the Cohen-Mansfield Agitation Inventory (CMAI). Motion features were significantly correlated with MMSE and CMAI scores.

Conclusion: Our findings suggest that changes of everyday behavior are detectable in accelerometric behavior protocols even in the absence of major clinical behavioral impairments in AD.

Citing Articles

An experimental framework for conjoint measures of olfaction, navigation, and motion as pre-clinical biomarkers of Alzheimer's disease.

Biljman K, Gozes I, Lam J, Li V J Alzheimers Dis Rep. 2025; 8(1):1722-1744.

PMID: 40034341 PMC: 11863766. DOI: 10.1177/25424823241307617.


Digital Biomarkers for the Assessment of Non-Cognitive Symptoms in Patients with Dementia with Lewy Bodies: A Systematic Review.

Sjaelland N, Gramkow M, Hasselbalch S, Frederiksen K J Alzheimers Dis. 2024; 100(2):431-451.

PMID: 38943394 PMC: 11307079. DOI: 10.3233/JAD-240327.


Early Stage Detection of Alzheimer's Disease With Microsoft Azure Based Deep Learning.

Mittal K Res Sq. 2023; .

PMID: 38014038 PMC: 10680911. DOI: 10.21203/rs.3.rs-3352620/v1.


Detection of Alzheimer's Disease Based on Cloud-Based Deep Learning Paradigm.

Pruthviraja D, Nagaraju S, Mudligiriyappa N, Raisinghani M, Khan S, Alkhaldi N Diagnostics (Basel). 2023; 13(16).

PMID: 37627946 PMC: 10453097. DOI: 10.3390/diagnostics13162687.


Designing the next-generation clinical care pathway for Alzheimer's disease.

Hampel H, Au R, Mattke S, van der Flier W, Aisen P, Apostolova L Nat Aging. 2023; 2(8):692-703.

PMID: 37118137 PMC: 10148953. DOI: 10.1038/s43587-022-00269-x.